{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&answeringDeptSortName=Health+and+Social+Care&dateTabled=2019-01-28", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?houseId=2&answeringDeptSortName=Health+and+Social+Care&dateTabled=2019-01-28", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&answeringDeptSortName=Health+and+Social+Care&dateTabled=2019-01-28&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&houseId=2&answeringDeptSortName=Health+and+Social+Care&dateTabled=2019-01-28", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&answeringDeptSortName=Health+and+Social+Care&dateTabled=2019-01-28", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&answeringDeptSortName=Health+and+Social+Care&dateTabled=2019-01-28", "items" : [{"_about" : "http://data.parliament.uk/resources/1049566", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1049566/answer", "answerText" : {"_value" : "<p>Perinatal mental illness covers a wide range of conditions. Although the Government has made no formal assessment of the links between perinatal mental health and intergenerational poverty, we stated in the Five Year Forward View for Mental Health that if left untreated, it can have significant and long-lasting effects not only on the woman but also on the emotional, social and cognitive development of children.<\/p><p>The Government is committed to improving both the detection and treatment of perinatal mental illness. General practitioners and primary care teams have a crucial role in supporting the identification and treatment of perinatal mental illness, including post-natal depression, and are part of an integrated pathway of services. Support includes monitoring early onset conditions, providing pre-conception counselling and referring women to specialist mental health services, including Improving Access to Psychological Therapies services and specialist perinatal community teams, if necessary.<\/p><p>To date, NHS England and Health Education England has also funded training for over 3,000 staff and professionals in mental health, maternity services and primary care to better identify and support women with perinatal mental health needs.<\/p><p>We are investing £365 million from 2015/16 to 2020/21 in perinatal mental health services to ensure that by 2020/21 at least 30,000 more women each year are able to access evidence-based specialist mental health care during the perinatal period. This investment is designed to improve access to specialist perinatal mental health services across England, resulting in better outcomes for women and their families.<\/p><p>In addition, the NHS Long Term Plan, includes a commitment for a further 24,000 women to be able to access specialist perinatal mental health care by 2023/24, building on the additional 30,000 women who will access these services each year by 2020/21 under pre-existing plans. Specialist care will also be available from preconception to 24 months after birth, which will provide an extra year of support.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-11T13:47:54.623Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Pregnancy: Mental Illness"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what assessment they have made of whether perinatal mental illnesses are being adequately identified and treated; whether they have made any assessment of the links between (1) perinatal mental illness and emotional and behavioural problems in children, and (2) perinatal mental illness and intergenerational cycles of poverty; whether, as a result of any such assessment, they intend to take steps to tackle any under-identification of perinatal mental illness; and if so, what steps.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4564", "label" : {"_value" : "Biography information for Lord Bird"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Bird"}
      ], "uin" : "HL13154"}
    , {"_about" : "http://data.parliament.uk/resources/1049571", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1049571/answer", "answerText" : {"_value" : "<p>We have made no assessment of the number of independent healthcare providers who have provided data to the Royal College of Anaesthetists. We encourage transparency and data sharing in the interest of improving care.<\/p><p>Private providers providing National Health Service funded services should meet all of the requirements in respect of information governance that we place on NHS organisations and the quality of services would be monitored through the commissioning contract.<\/p><p>The Paterson Inquiry, which is due to report its conclusions and recommendations in summer 2019, will consider how and when information is shared between the NHS and the independent sector.<\/p><p> <\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-11T17:39:49.787Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Surgery: Allergies"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the number of independent healthcare providers who have provided data to the Royal College of Anaesthetists\u2019 national audit project on life-threatening allergic reaction during surgery; and what steps, if any, they intend to take to encourage such providers to provide such data.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3609", "label" : {"_value" : "Biography information for Baroness Finlay of Llandaff"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Finlay of Llandaff"}
      ], "uin" : "HL13158"}
    , {"_about" : "http://data.parliament.uk/resources/1049572", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1049572/answer", "answerText" : {"_value" : "<p>The Care Quality Commission (CQC) is the independent regulator of health and adult social care in England, and is responsible for ensuring that all health and social care services provide people with safe, effective, compassionate, high quality care; and encouraging services to improve. The CQC uses the same assessment framework of key lines of enquiry and ratings characteristics for its inspections and ratings across all healthcare service types, including both National Health Service and independent sector providers.<\/p><p>Key standards and recommendations on patient care made by medical Royal Colleges are reflected in the CQC\u2019s inspection frameworks and guidance for specific healthcare services, and the CQC reports on where providers are following that guidance.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-11T13:54:54.943Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hospitals: Private Sector"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what steps they will take to ensure that patients treated in independent healthcare providers\u2019 hospitals will receive a uniform standard of care; and what steps they will take to ensure that any recommendations on patient care from medical royal colleges are adopted by such providers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3609", "label" : {"_value" : "Biography information for Baroness Finlay of Llandaff"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Finlay of Llandaff"}
      ], "uin" : "HL13159"}
    , {"_about" : "http://data.parliament.uk/resources/1049579", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1049579/answer", "answerText" : {"_value" : "<p>The Department has had no such discussions with NHS England on ensuring liothyronine is prescribed in accordance with the National Institute for Health and Care Excellence guidelines, nor does the Department intend to conduct such an assessment.<\/p><p>The Regional Medicines Optimising Committee published its latest guidance on the prescribing of liothyronine in November and we can confirm NHS England is working closely with clinical commissioning groups (CCGs) on the prescribing of liothyronine to support them with the implementation of guidance for CCGs on items which should not be routinely prescribed in primary care.<\/p><p>CCGs are expected to have regard to national guidance, and are responsible for developing their own local approaches to its implementation taking into account local priorities and needs.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "HL13167"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-11T17:39:28.657Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Liothyronine"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what discussions they have had, or intend to have, with NHS England on ensuring Liothyronine (T3) is prescribed in accordance with NICE guidelines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"}
      ], "uin" : "HL13166"}
    , {"_about" : "http://data.parliament.uk/resources/1049580", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1049580/answer", "answerText" : {"_value" : "<p>The Department has had no such discussions with NHS England on ensuring liothyronine is prescribed in accordance with the National Institute for Health and Care Excellence guidelines, nor does the Department intend to conduct such an assessment.<\/p><p>The Regional Medicines Optimising Committee published its latest guidance on the prescribing of liothyronine in November and we can confirm NHS England is working closely with clinical commissioning groups (CCGs) on the prescribing of liothyronine to support them with the implementation of guidance for CCGs on items which should not be routinely prescribed in primary care.<\/p><p>CCGs are expected to have regard to national guidance, and are responsible for developing their own local approaches to its implementation taking into account local priorities and needs.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "HL13166"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-11T17:39:28.707Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Liothyronine"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government whether they intend to conduct an assessment of the impact of the withdrawal of Liothyronine (T3) on patients as a result of Clinical Commissioning Groups misinterpreting or failing to follow NHS England's guidance on the prescription of that drug.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"}
      ], "uin" : "HL13167"}
    , {"_about" : "http://data.parliament.uk/resources/1049581", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1049581/answer", "answerText" : {"_value" : "<p>All United Kingdom marketing authorisation holders of liothyronine are obliged to ensure that the product complies with the minimum standard as specified in the updated British Pharmacopoeia monograph for liothyronine tablets. Liothyronine on the market in other European Union Member States may not comply with the updated British Pharmacopoeia monograph and therefore would not be considered therapeutically equivalent.<\/p><p>Liothyronine is an unbranded generic medicine. The Department encourages competition between suppliers of unbranded generic medicines to keep prices down. This generally works well and has led to some of the lowest prices in Europe. Concerns about anti-competitive behaviour are a matter for the Competition and Markets Authority (CMA) to investigate.<\/p><p>Liothyronine, marketed by Advanz Pharma (formerly Concordia), is currently the subject of an investigation by the CMA. The CMA has provisionally found that the company abused its dominant position to overcharge the National Health Service by millions of pounds for liothyronine tablets. A provisional decision does not necessarily lead to an infringement decision. Where companies have breached competition law, the Department will seek damages and invest that money back into the NHS.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-11T13:48:58.55Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Liothyronine"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what steps they are taking to ensure that Liothyronine (T3) is purchased at a cost in line with other EU countries.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2024", "label" : {"_value" : "Biography information for Lord Hunt of Kings Heath"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Hunt of Kings Heath"}
      ], "uin" : "HL13168"}
    , {"_about" : "http://data.parliament.uk/resources/1049587", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1049587/answer", "answerText" : {"_value" : "<p>The Social Care Green Paper remains a priority for this Government and the Department. We will be publishing the Green Paper at the earliest opportunity.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-11T13:53:50.14Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Social Services"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government when they expect to publish their Green Paper on social care.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/2492", "label" : {"_value" : "Biography information for Lord Lipsey"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Lipsey"}
      ], "uin" : "HL13173"}
    , {"_about" : "http://data.parliament.uk/resources/1049589", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1049589/answer", "answerText" : {"_value" : "<p>The second Life Sciences Sector Deal, published by the Government in December 2018, announced that Genomics England will undertake development work on a new service to enable volunteers to pay for a personalised report on their unique genetic makeup.<\/p><p>Genomics England are in the early stages of developing the scheme, working with patient groups and the public as well as key partners, including the National Health Service.<\/p><p>It will be developed in line with the founding principles of the NHS and established to the highest ethical standards.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "HL13176"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-11T17:38:56.987Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Genetics"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government who authorised NHS England's scheme to allow people to pay to have their genes sequenced on the condition that they share their data.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4333", "label" : {"_value" : "Biography information for Lord Scriven"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Scriven"}
      ], "uin" : "HL13175"}
    , {"_about" : "http://data.parliament.uk/resources/1049591", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1049591/answer", "answerText" : {"_value" : "<p>The second Life Sciences Sector Deal, published by the Government in December 2018, announced that Genomics England will undertake development work on a new service to enable volunteers to pay for a personalised report on their unique genetic makeup.<\/p><p>Genomics England are in the early stages of developing the scheme, working with patient groups and the public as well as key partners, including the National Health Service.<\/p><p>It will be developed in line with the founding principles of the NHS and established to the highest ethical standards.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "HL13175"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-11T17:38:57.037Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Genetics"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the ethics implications of NHS England's scheme to allow people to pay to have their genes sequenced on the condition that they share their data.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4333", "label" : {"_value" : "Biography information for Lord Scriven"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Scriven"}
      ], "uin" : "HL13176"}
    , {"_about" : "http://data.parliament.uk/resources/1049596", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1049596/answer", "answerText" : {"_value" : "<p>Contraception supplied in sexual and reproductive health services in England is monitored and recorded nationally through the Sexual and Reproductive Health Activity Data Set, which includes data on age, consultation medium and contraception main method. The data is collected from all sexual and reproductive health services, including some general practitioner (GP) services, and will continue after the National Health Service goes paperless. Data by age is not collected where contraception is supplied by general practice under the GP Contract.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"}
        }
        , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"}
        , "dateOfAnswer" : {"_value" : "2019-02-11", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-11T13:40:30.79Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-28", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Contraceptives"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government whether they intend to monitor and record contraceptive use in the UK once the NHS goes paperless in 2020; and if so, whether they will record types of contraceptives being used according to age group.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/200", "label" : {"_value" : "Biography information for Baroness Tonge"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Tonge"}
      ], "uin" : "HL13181"}
    ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&houseId=2&answeringDeptSortName=Health+and+Social+Care&dateTabled=2019-01-28", "page" : 0, "startIndex" : 1, "totalResults" : 14, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}